These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
784 related articles for article (PubMed ID: 26878778)
1. Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt. Jia Y; Wu C; Kim J; Kim B; Lee SJ J Nutr Biochem; 2016 Feb; 28():9-18. PubMed ID: 26878778 [TBL] [Abstract][Full Text] [Related]
2. The natural carotenoid astaxanthin, a PPAR-α agonist and PPAR-γ antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid-loaded hepatocytes. Jia Y; Kim JY; Jun HJ; Kim SJ; Lee JH; Hoang MH; Hwang KY; Um SJ; Chang HI; Lee SJ Mol Nutr Food Res; 2012 Jun; 56(6):878-88. PubMed ID: 22707263 [TBL] [Abstract][Full Text] [Related]
3. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089 [TBL] [Abstract][Full Text] [Related]
4. Lemon Balm Extract ALS-L1023 Regulates Obesity and Improves Insulin Sensitivity via Activation of Hepatic PPARα in High-Fat Diet-Fed Obese C57BL/6J Mice. Lee D; Shin Y; Roh JS; Ahn J; Jeoong S; Shin SS; Yoon M Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549364 [TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271 [TBL] [Abstract][Full Text] [Related]
6. Ursolic acid improves lipid and glucose metabolism in high-fat-fed C57BL/6J mice by activating peroxisome proliferator-activated receptor alpha and hepatic autophagy. Jia Y; Kim S; Kim J; Kim B; Wu C; Lee JH; Jun HJ; Kim N; Lee D; Lee SJ Mol Nutr Food Res; 2015 Feb; 59(2):344-54. PubMed ID: 25418615 [TBL] [Abstract][Full Text] [Related]
7. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats. Zhang Y; Cui Y; Wang XL; Shang X; Qi ZG; Xue J; Zhao X; Deng M; Xie ML Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065 [TBL] [Abstract][Full Text] [Related]
8. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase. Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686 [TBL] [Abstract][Full Text] [Related]
9. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism. Yin Y; Yu Z; Xia M; Luo X; Lu X; Ling W Eur J Clin Invest; 2012 Nov; 42(11):1189-96. PubMed ID: 22958216 [TBL] [Abstract][Full Text] [Related]
10. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation. Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330 [TBL] [Abstract][Full Text] [Related]
11. A Novel Peroxisome Proliferator-activated Receptor (PPAR)α Agonist and PPARγ Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice. Shiomi Y; Yamauchi T; Iwabu M; Okada-Iwabu M; Nakayama R; Orikawa Y; Yoshioka Y; Tanaka K; Ueki K; Kadowaki T J Biol Chem; 2015 Jun; 290(23):14567-81. PubMed ID: 25907553 [TBL] [Abstract][Full Text] [Related]
12. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice. Li X; Wang Z; Klaunig JE Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707 [TBL] [Abstract][Full Text] [Related]
14. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice. Lee H; Ahn J; Shin SS; Yoon M Int J Obes (Lond); 2019 Aug; 43(8):1620-1630. PubMed ID: 30283077 [TBL] [Abstract][Full Text] [Related]
15. Hepatocyte-specific Ptpn6 deletion promotes hepatic lipid accretion, but reduces NAFLD in diet-induced obesity: potential role of PPARγ. Xu E; Forest MP; Schwab M; Avramoglu RK; St-Amand E; Caron AZ; Bellmann K; Shum M; Voisin G; Paquet M; Montoudis A; Lévy E; Siminovitch KA; Neel BG; Beauchemin N; Marette A Hepatology; 2014 May; 59(5):1803-15. PubMed ID: 24327268 [TBL] [Abstract][Full Text] [Related]
16. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice. Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114 [TBL] [Abstract][Full Text] [Related]
17. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα. Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923 [TBL] [Abstract][Full Text] [Related]